Measles-containing-vaccine first-dose (MCV1) immunization coverage in Jamaica
Jamaica: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 93.0% in 2025. ▲ Rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Jamaica, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine first-dose (mcv1) immunization coverage in Jamaica stood at 93.0%.
Compared with earlier readings it is down 1.1% on the previous year and up 2.2% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Jamaica peaked at 95.0% in 2016 and was at its lowest, 76.0%, in 2007.
That places Jamaica 72nd out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Jamaica, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 88.0% | — |
| 2001 | 85.0% | -3.4% |
| 2002 | 86.0% | +1.2% |
| 2003 | 78.0% | -9.3% |
| 2004 | 86.0% | +10.3% |
| 2005 | 84.0% | -2.3% |
| 2006 | 87.0% | +3.6% |
| 2007 | 76.0% | -12.6% |
| 2008 | 88.0% | +15.8% |
| 2009 | 88.0% | +0.0% |
| 2010 | 89.0% | +1.1% |
| 2011 | 88.0% | -1.1% |
| 2012 | 93.0% | +5.7% |
| 2013 | 94.0% | +1.1% |
| 2014 | 92.0% | -2.1% |
| 2015 | 91.0% | -1.1% |
| 2016 | 95.0% | +4.4% |
| 2017 | 95.0% | +0.0% |
| 2018 | 89.0% | -6.3% |
| 2019 | 94.0% | +5.6% |
| 2020 | 93.0% | -1.1% |
| 2021 | 88.0% | -5.4% |
| 2022 | 91.0% | +3.4% |
| 2023 | 93.0% | +2.2% |
| 2024 | 94.0% | +1.1% |
| 2025 | 93.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.6% | 76.0% | 88.0% | 10 |
| 2010s | 92.0% | 88.0% | 95.0% | 10 |
| 2020s | 92.0% | 88.0% | 94.0% | 6 |
Countries ranked near Jamaica
More health data for Jamaica
- Un projection of annual infant deaths, annual growth rate -3.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3325 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,308 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Population ages 0-14, female, annual growth rate -2.32 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0898 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.29 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0931 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Jamaica?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Jamaica was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Jamaica?
- The highest recorded value was 95.0% in 2016.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Jamaica?
- The lowest recorded value was 76.0% in 2007.
- How does Jamaica rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Jamaica ranks 72nd out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Jamaica?
- Over the last ten years it is up 2.2%. The long-run trend across the full record is rising.
- Where does this Jamaica data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).